Zobrazeno 1 - 10
of 457
pro vyhledávání: '"Padula SJ"'
Autor:
Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, USA. pmease@philipmease.com.; Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA, 98122, USA. pmease@philipmease.com., Kellner H; Hospital Neuwittelsbach, Munich, Germany., Morita A; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Aslanyan S; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Topp AS; AbbVie Inc., North Chicago, IL, USA., Eldred A; AbbVie Inc., North Chicago, IL, USA., Behrens F; CIRI/Rheumatology and Fraunhofer Institute IME, Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany., Papp KA; K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada.
Publikováno v:
Rheumatology and therapy [Rheumatol Ther] 2022 Oct; Vol. 9 (5), pp. 1361-1375. Date of Electronic Publication: 2022 Aug 05.
Autor:
Mrowietz U; Psoriasis-Center at the Department of Dermatology, University Medical Center, Schleswig-Holstein, Campus Kiel, Kiel, Germany. umrowietz@dermatology.uni-kiel.de., Burden AD; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Pinter A; Department of Dermatology, Venereology and Allergology, University Clinic Frankfurt Am Main, Frankfurt am Main, Germany., Reich K; Center of Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schäkel K; Department of Dermatology, Universitätsklinikum Heidelberg, Heidelberg, Germany., Baum P; Boehringer Ingelheim International GmbH, Biberach, Germany., Datsenko Y; Boehringer Ingelheim International GmbH, Biberach, Germany., Deng H; Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, China., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Thoma C; Boehringer Ingelheim International GmbH, Biberach, Germany., Bissonnette R; Innovaderm Research Inc., Montreal, Quebec, Canada.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2021 Apr; Vol. 11 (2), pp. 571-585. Date of Electronic Publication: 2021 Mar 04.
Autor:
Tsuda Y; Nippon Boehringer Ingelheim Co. Ltd, Kobe, Japan., Grimaldi C; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Huang F; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Benediktus E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Yagi N; Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Jang IJ; Seoul National University Hospital Clinical Trials Center, Seoul, Korea., Steffgen J; Boehringer Ingelheim International GmbH, Biberach, Germany.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Apr; Vol. 87 (4), pp. 2000-2013. Date of Electronic Publication: 2020 Dec 09.
Autor:
Litzenburger T; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Steffgen J; Boehringer Ingelheim International GmbH, Biberach, Germany., Benediktus E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Müller F; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Schultz A; CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany., Klein E; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Ramanujam M; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Harcken C; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Gupta A; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Wu J; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Wiebe S; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Li X; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Flack M; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Visvanathan S; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Hünnemeyer A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hui J; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Apr; Vol. 87 (4), pp. 1824-1838. Date of Electronic Publication: 2020 Nov 20.
Autor:
Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA sudha.visvanathan@boehringer-ingelheim.com., Daniluk S; ClinicMed Badurski and Partners, Białystok, Poland., Ptaszyński R; Rheumatica, Warsaw, Poland., Müller-Ladner U; Justus Liebig University Giessen, Bad Nauheim, Germany., Ramanujam M; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Rosenstock B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Eleftheraki AG; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Vinisko R; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Petříková A; CTCenter MaVe, Olomouc, Czech Republic., Kellner H; Centre for Inflammatory Joint Diseases, Munich, Germany., Dokoupilova E; Medical Plus, s.r.o, Uherské Hradiště, Czech Republic.; Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic., Kwiatkowska B; Prof. Eleonora Reicher Memorial National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Alten R; Schlosspark-Klinik, Berlin, Germany., Schwabe C; Auckland Clinical Studies, Auckland, New Zealand., Baum P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Joseph D; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Fine JS; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Steffgen J; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Jun; Vol. 78 (6), pp. 754-760. Date of Electronic Publication: 2019 Mar 22.
Autor:
Visvanathan S; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn. Electronic address: sudha.visvanathan@boehringer-ingelheim.com., Baum P; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany., Vinisko R; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn., Schmid R; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany., Flack M; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn., Lalovic B; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn., Kleiner O; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany., Fuentes-Duculan J; Laboratory for Investigative Dermatology, Rockefeller University, New York, NY., Garcet S; Laboratory for Investigative Dermatology, Rockefeller University, New York, NY., Davis JW; AbbVie, North Chicago, Ill., Grebe KM; AbbVie, Worcester, Mass., Fine JS; Boehringer Ingelheim Pharmaceuticals, Ridgefield, Conn., Padula SJ; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany., Krueger JG; Laboratory for Investigative Dermatology, Rockefeller University, New York, NY.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Jun; Vol. 143 (6), pp. 2158-2169. Date of Electronic Publication: 2018 Dec 20.
Autor:
Bachelez H; Sorbonne Paris Cité Université Paris Diderot, Paris, France herve.bachelez@aphp.fr., Choon SE; Monash University Malaysia, Johor Bahru, Malaysia., Marrakchi S; Hedi Chaker University Hospital, Sfax, Tunisia., Burden AD; University of Glasgow, Glasgow, United Kingdom., Tsai TF; National Taiwan University, Taipei, Taiwan., Morita A; Nagoya City University, Nagoya, Japan., Turki H; Hedi Chaker University Hospital, Sfax, Tunisia., Hall DB; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT., Shear M; Boehringer Ingelheim International, Biberach, Germany., Baum P; Boehringer Ingelheim International, Biberach, Germany., Padula SJ; Boehringer Ingelheim International, Ingelheim, Germany., Thoma C; Boehringer Ingelheim International, Biberach, Germany.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2019 Mar 07; Vol. 380 (10), pp. 981-983.
Autor:
Schwabe C; Auckland Clinical Studies Ltd, Auckland, New Zealand., Rosenstock B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Doan T; Boehringer Ingelheim Pty Limited, North Ryde, Australia., Hamilton P; Auckland Clinical Studies Ltd, Auckland, New Zealand., Dunbar PR; School of Biological Sciences and Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand., Eleftheraki AG; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Joseph D; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Hilbert J; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Schoelch C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Padula SJ; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Steffgen J; Boehringer Ingelheim International GmbH, Biberach, Germany.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2018 Dec; Vol. 58 (12), pp. 1566-1577. Date of Electronic Publication: 2018 Aug 16.
Autor:
Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Baum P; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Salas A; Hospital Clinic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Vinisko R; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Schmid R; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Grebe KM; AbbVie Inc., Worcester, MA, USA., Davis JW; AbbVie Inc., North Chicago, IL, USA., Wallace K; AbbVie Inc., North Chicago, IL, USA., Böcher WO; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Padula SJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Fine JS; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Panés J; Hospital Clinic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Publikováno v:
Journal of Crohn's & colitis [J Crohns Colitis] 2018 Nov 09; Vol. 12 (10), pp. 1170-1179.
Autor:
Feagan BG; Western University, Robarts Clinical Trials, London, ON, Canada. Electronic address: brian.feagan@robartsinc.com., Panés J; Hospital Clinic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Ferrante M; University Hospitals Leuven, Leuven, Belgium., Kaser A; University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., D'Haens GR; Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Sandborn WJ; University of California San Diego, La Jolla, CA, USA., Louis E; University Hospital CHU Liège, Liège, Belgium., Neurath MF; University of Erlangen-Nuremberg, Erlangen, Germany., Franchimont D; Erasme University Hospital, Brussels, Belgium., Dewit O; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Seidler U; Hannover Medical School, Hannover, Germany., Kim KJ; Asan Medical Center, Seoul, South Korea., Selinger C; St James's University Hospital, Leeds, UK., Padula SJ; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany., Herichova I; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Robinson AM; AbbVie Inc, North Chicago, IL, USA., Wallace K; AbbVie Inc, North Chicago, IL, USA., Zhao J; AbbVie Inc, North Chicago, IL, USA., Minocha M; AbbVie Inc, North Chicago, IL, USA., Othman AA; AbbVie Inc, North Chicago, IL, USA., Soaita A; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA., Visvanathan S; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA., Hall DB; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA., Böcher WO; Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany.
Publikováno v:
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2018 Oct; Vol. 3 (10), pp. 671-680. Date of Electronic Publication: 2018 Jul 25.